Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Posted on by ScienceFather

Dr. Liang Yang | Bone biomaterials | Best Researcher Award

Dr at Shanghai Sixth People’s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, China

Liang Yang, MD, is a 33-year-old orthopedic surgeon at Shanghai Sixth People’s Hospital, affiliated with Shanghai Jiao Tong University School of Medicine, China. Specializing in biomimetic materials for orthopedic reconstruction, he focuses on repairing bone defects under pathological conditions like osteoporosis. His innovative work on hydroxyapatite (HA) modification and chiral-engineered biomaterials has led to significant advancements in bone healing and regeneration.

Publication Profile

orcid

🎓 Education

Liang Yang earned his MD in Orthopedics from Shanghai Jiao Tong University School of Medicine. His academic pursuits have centered on advancing orthopedic materials, particularly through modifying HA to enhance bioactivity. Yang’s education combined intensive clinical training with cutting-edge research on bioactive ion doping (Sr2+/Fe3+) in HA for bone regeneration, culminating in impactful publications and novel biomaterial development. His studies positioned him at the forefront of orthopedic biomimetics.

💼 Experienc

Dr. Yang has dedicated his career to orthopedic surgery and biomaterial research at Shanghai Sixth People’s Hospital. His expertise spans developing bioactive hydroxyapatite materials, pioneering chiral-engineered biomaterials, and addressing osteoporosis-induced bone defects. Yang has led multiple research projects, resulting in publications in high-impact journals. His work reflects a seamless blend of surgical practice and translational research, bridging the gap between clinical needs and innovative material solutions.

🏆 Awards and Honors

Dr. Yang’s contributions to orthopedic biomaterials have earned him recognition in scientific and medical communities. His publications in journals like Advanced Science and Chem. Eng. J. have been widely cited. He received institutional awards for innovation in biomimetic material development and recognition from Shanghai Jiao Tong University for advancing orthopedic reconstruction techniques. His groundbreaking work on chiral hydroxyapatite further positioned him as a leader in biomaterial innovation.

🔬 Research Focus

Liang Yang’s research focuses on biomimetic materials for orthopedic reconstruction, particularly hydroxyapatite (HA) modification to enhance bioactivity and bone regeneration. His work explores doping HA with Sr2+/Fe3+ ions to modulate immunoregulation, angiogenesis, and osteogenesis. Recently, Yang synthesized chiral hydroxyapatite (CHA) with enantiomer-dependent osseointegration properties, unveiling L-CHA’s superior potential for osteoporosis treatment. His research paves the way for next-gen chiral-engineered biomaterials in orthopedics.

Publications 📖

Chirality‐Induced Hydroxyapatite for Osteoporotic Osseointegration – Advanced Science, 2024. DOI: 10.1002/advs.202411602.

Focus: Enantioselective bone-implant interactions to enhance osseointegration in osteoporosis.

Graphene Oxide Quantum Dot Scaffold – Advanced Functional Materials, 2023. DOI: 10.1002/ADFM.202211709.

Focus: Immuno-inductive angiogenesis and nerve regeneration via biocompatible nanoscaffolds.

Cryogenically 3D Printed Biomimetic Scaffolds – Chemical Engineering Journal, 2022. DOI: 10.1016/J.CEJ.2021.133459.

Focus: Bone tissue engineering using Sr2+/Fe3+ doped hydroxyapatite scaffolds.

Biomimetic Porous Scaffolds – Biomedical Materials, 2022. DOI: 10.1088/1748-605X/ac4b45.

Focus: Accelerated angiogenesis/osteogenesis with doped hydroxyapatite.

3D Printed Porous Scaffolds for Bone Tissue – Biofabrication, 2021. DOI: 10.1088/1758-5090/ABCF8D.

Focus: Bioactive scaffolds enhancing bone regeneration.

Anterior Acetabular Fracture Fixation – BMC Musculoskeletal Disorders, 2021. DOI: 10.1186/S12891-021-04034-W.

Focus: Surgical fixation methods for acetabular fractures.

Cartilage Changes with Glucocorticoids – Cartilage, 2021. DOI: 10.1177/1947603520978574.

Focus: Epiphyseal cartilage effects in glucocorticoid-treated mice.

🔹 Conclusion

Dr. Liang Yang’s pioneering work in chiral hydroxyapatite and bioactive bone materials makes him a strong contender for the Best Researcher Award. His contributions to orthopedic biomaterials, innovative solutions for bone defects, and significant publication record underscore his potential to drive transformative advancements in orthopedic surgery and bone regeneration.

Prof Dr. Satya Prakash | Functional Biomaterial Award | Best Researcher Award

Posted on by ScienceFather

Prof Dr. Satya Prakash | Functional Biomaterial Award | Best Researcher Award

Prof Dr. Satya Prakash, McGill University, Canada

Prof Dr. Satya Prakash is academic and researcher in the field of renewable energy, holds a PhD in Bio systems Engineering from Kangwon National University, South Korea. His academic journey has been marked by a profound dedication to advancing solar energy technologies, specifically in solar thermal harvesting and its integration into agricultural and architectural applications.

Professional Profiles:

Google scholar

🔬 Research Funding:

Prof. Satya Prakash has secured over 48 funded research grants, demonstrating his ability to attract significant financial support for his research endeavors. Additionally, he currently maintains four active grants, indicating the ongoing relevance and impact of his work.

🏆 Distinguished James McGill Professor Endowment:

This prestigious endowment recognizes Prof. Prakash as an outstanding original researcher of world-class caliber and an international leader in his field. It provides eight years of salary endowment and citation, further cementing his reputation and contributions.

💰 Salary Endowments:

Prof. Prakash holds four salary endowments, including the CIHR New Investigator award and the FRSQ Chercher-Boursier Junior 1 award, which provide substantial financial support and relieve him of teaching and administrative responsibilities, allowing him to focus on research.

🎖️ Recognition and Awards:

With over 27 awards, honors, and recognitions to his name, including the esteemed Academician title from the Royal Society of Canada, Prof. Prakash’s contributions to academia and research are widely celebrated and acknowledged.

📝 Patents and Spin Offs:

Prof. Prakash’s innovative work has led to the development of four successful spin-offs and over 75 approved or pending patents. This demonstrates his commitment to translating research into tangible applications that benefit society and industry.

📊 Citation Metrics (Google Scholar):

Citations: 20,298

h-index: 64

i10-index: 445

Person/Entity 2:

Citations: 8,160

h-index: 39

i10-index: 180

📖 Publications  Top Note :

Microbiome, probiotics and neurodegenerative diseases: deciphering the gut brain axis

Authors: S Westfall, N Lomis, I Kahouli, SY Dia, SP Singh, S Prakash

Published in: Cellular and molecular life sciences, 74, 3769-3787, 2017

Cholesterol-lowering efficacy of a microencapsulated bile salt hydrolase-active Lactobacillus reuteri NCIMB 30242 yoghurt formulation in hypercholesterolaemic …

Authors: ML Jones, CJ Martoni, M Parent, S Prakash

Published in: British Journal of Nutrition, 107 (10), 1505-1513, 2012

Gut microbiota: next frontier in understanding human health and development of biotherapeutics

Authors: S Prakash, L Rodes, M Coussa-Charley, C Tomaro-Duchesneau

Published in: Biologics: targets and therapy, 71-86, 2011

Cholesterol lowering and inhibition of sterol absorption by Lactobacillus reuteri NCIMB 30242: a randomized controlled trial

Authors: ML Jones, CJ Martoni, S Prakash

Published in: European journal of clinical nutrition, 66 (11), 1234-1241, 2012

Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy

Authors: S Prakash, M Malhotra, W Shao, C Tomaro-Duchesneau, S Abbasi

Published in: Advanced drug delivery reviews, 63 (14-15), 1340-1351, 2011

Carbon nanotube lipid drug approach for targeted delivery of a chemotherapy drug in a human breast cancer xenograft animal model

Authors: W Shao, A Paul, B Zhao, C Lee, L Rodes, S Prakash

Published in: Biomaterials, 34 (38), 10109-10119, 2013

Pallidol, a resveratrol dimer from Cissus pallida

Authors: MA Khan, SG Nabi, S Prakash, A Zaman

Published in: Phytochemistry, 25 (8), 1945-1948, 1986

Seismic performance of circular RC columns subjected to axial force, bending, and torsion with low and moderate shear

Authors: S Prakash, A Belarbi, YM You

Published in: Engineering Structures, 32 (1), 46-59, 2010

Superior cell delivery features of poly (ethylene glycol) incorporated alginate, chitosan, and poly-L-lysine microcapsules

Authors: T Haque, H Chen, W Ouyang, C Martoni, B Lawuyi, AM Urbanska, …

Published in: Molecular Pharmaceutics, 2 (1), 29-36, 2005

High temperature oxidation studies of detonation-gun-sprayed Cr3C2–NiCr coating on Fe-and Ni-based superalloys in air under cyclic condition at 900° C

Authors: S Kamal, R Jayaganthan, S Prakash

    • Published in: Journal of alloys and compounds, 472 (1-2), 378-389, 2009